Targeting the PD-1 Axis with Pembrolizumab for Recurrent or Metastatic Cancer of the Uterine Cervix: A Brief Update

Even though cervical cancer is partly preventable, it still poses a great public health problem throughout the world. Current therapies have vastly improved the clinical outcomes of cervical cancer patients, but progress in new systemic treatment modalities has been slow in the last years. Especiall...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhoeven, Yannick, Quatannens, Delphine, Trinh, Xuan Bich, Wouters, An, Smits, Evelien L.J., Lardon, Filip, De Waele, Jorrit, van Dam, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917788/
https://www.ncbi.nlm.nih.gov/pubmed/33670397
http://dx.doi.org/10.3390/ijms22041807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917788/
https://www.ncbi.nlm.nih.gov/pubmed/33670397
http://dx.doi.org/10.3390/ijms22041807

Ejemplares similares